Foundational Science and Mechanisms of Disease

A 62-year-old man comes to the emergency department complaining of severe, diffuse muscle pain and dark urine for the past 2 days. He has a history of hypertension, hyperlipidemia, and type 2 diabetes mellitus. His daily medications include lisinopril, amlodipine, metformin, and atorvastatin. Ten days ago, he was evaluated at an urgent care clinic for community-acquired pneumonia and was prescribed a 7-day course of clarithromycin, which he completed 3 days ago. His temperature is 37.2°C (99.0°F), blood pressure is 134/82 mm Hg, and pulse is 78/min. Physical examination shows diffuse muscle tenderness on palpation. Laboratory studies show a serum creatine kinase level of 8,500 U/L and an elevated serum creatinine of 1.9 mg/dL (baseline 1.0 mg/dL). Urinalysis is positive for blood but shows no red blood cells on microscopy. Which of the following mechanisms best explains this patient's current presentation?

Match each medically important fungal pathogen with its primary morphologic or biochemical mechanism for evading host immune defenses.

A 45-year-old agricultural worker presents to the emergency department with a 2-day history of progressively worsening jaw stiffness, difficulty swallowing, and painful, uncontrollable muscle spasms in his back. Vital signs show a heart rate of 112/min and blood pressure of 165/95 mm Hg. Physical examination is notable for severe trismus, risus sardonicus, and opisthotonos. He reports stepping on a rusty nail in a barn two weeks ago and has not received any vaccinations since early childhood. The pathogenic mechanism underlying this patient's condition is driven by a potent protein exotoxin. Arrange the following steps in the correct chronological sequence to describe the molecular pathogenesis of this exotoxin, from initial neuronal contact to its ultimate synaptic effect.

Match each pharmacodynamic agent or modulator to its corresponding effect on the dose-response curve.

A $45$-year-old man is admitted to the intensive care unit with septic shock secondary to severe *Staphylococcus aureus* pneumonia. He requires massive intravenous fluid resuscitation and initiation of vasopressor support. Laboratory studies reveal a serum creatinine of $3.2\text{ mg/dL}$, representing a $75\%$ reduction in his estimated glomerular filtration rate compared to his baseline. Intravenous vancomycin therapy is planned. Capillary leak syndrome and aggressive fluid resuscitation have significantly increased this patient's extracellular fluid compartment, effectively doubling the drug's apparent volume of distribution ($V_d$). Assuming the target steady-state peak plasma concentration remains unchanged, which of the following pharmacokinetic-based dosing adjustments is most appropriate for this patient compared to a healthy adult of the same weight?

A 34-year-old woman with a history of bipolar disorder has been well-controlled on a stable daily dose of lithium carbonate for the past two years. She recently joined a local running club and developed bilateral knee pain. To manage the discomfort, she started taking over-the-counter naproxen regularly. Five days later, she presents to her primary care physician complaining of new-onset nausea, coarse hand tremors, and feeling unsteady when walking. Her vital signs are within normal limits. Laboratory testing reveals a serum lithium concentration of 1.9 mEq/L (therapeutic range: 0.6-1.2 mEq/L). Which of the following pharmacokinetic mechanisms best explains this patient's laboratory findings and clinical presentation?

A 68-year-old woman is evaluated in the hospital for a deep vein thrombosis of the left lower extremity. She is prescribed oral warfarin. However, a bridging parenteral anticoagulant is not initiated. Three days later, the patient develops painful, well-demarcated, erythematous lesions on her abdomen and breasts that rapidly progress to purpuric necrosis and eschar formation. This patient's dermatologic complication is most directly caused by a precipitous decline in the plasma activity of which of the following?

A 52-year-old man with locally advanced oropharyngeal squamous cell carcinoma is currently undergoing the third week of a definitive fractionated radiation therapy regimen. He presents with severe oral pain, erythema, and ulcerations of the buccal mucosa, consistent with radiation-induced mucositis. The ionizing radiation causes extensive DNA double-strand breaks in the rapidly dividing basal epithelial cells, ultimately committing these cells to programmed cell death. Arrange the following subcellular biochemical events in the correct chronological order from the initial molecular trigger to the execution of this cellular injury pathway.

A 75-year-old man is transferred from a skilled nursing facility to the intensive care unit for hypotension, fever, and severe abdominal pain. He recently completed a 10-day course of clindamycin for aspiration pneumonia. Vital signs show a temperature of 38.9°C (102.0°F), pulse of 122/min, and blood pressure of 86/50 mm Hg. Physical examination reveals a distended abdomen with diffuse tenderness and guarding. Laboratory studies show a leukocyte count of 32,000/mm³ and serum creatinine of 2.4 mg/dL. A non-contrast CT scan of the abdomen demonstrates severe, diffuse colonic wall thickening with mucosal edema (thumbprinting). Stool polymerase chain reaction is positive for Clostridioides difficile toxin genes. Arrange the following steps in the correct chronological sequence detailing the cellular pathogenesis of the primary toxin (Toxin B) responsible for this patient's mucosal necrosis.

A 24-year-old healthy male sustains a minor laceration to his forearm while cooking. Bleeding from the wound ceases within a few minutes due to an intact physiological hemostatic response. Arrange the following cellular and molecular events of hemostasis in the correct chronological order, beginning immediately after the initial vascular injury.

A 60-year-old man is admitted to the intensive care unit for a severe exacerbation of chronic obstructive pulmonary disease. He is started on a continuous intravenous infusion of theophylline at a rate of $40 \text{ mg/hr}$. Forty-eight hours later, his steady-state serum theophylline concentration is measured at $10 \text{ mg/L}$ (therapeutic range: $10-20 \text{ mg/L}$). His estimated volume of distribution ($V_d$) for theophylline is $40 \text{ L}$.

On hospital day 4, the patient develops a catheter-associated urinary tract infection, and empiric intravenous ciprofloxacin is added to his regimen. On hospital day 8, the patient complains of intractable nausea, palpitations, and tremors. An electrocardiogram shows sinus tachycardia. A repeat serum theophylline concentration is found to be $20 \text{ mg/L}$. The theophylline infusion rate had remained constant at $40 \text{ mg/hr}$.

The physician immediately stops the theophylline infusion to allow the drug concentration to fall to $10 \text{ mg/L}$ before restarting at a lower rate.

Assuming first-order elimination kinetics and that the volume of distribution remains unchanged, approximately how many hours will it take from the time the infusion is stopped for the serum theophylline concentration to decrease to $10 \text{ mg/L}$?

A 68-year-old man is hospitalized in the intensive care unit for septic shock secondary to a complicated intra-abdominal infection following a ruptured appendix. He has a prolonged hospital course complicated by acute respiratory distress syndrome requiring mechanical ventilation. During his third week of hospitalization, he develops a new-onset fever, increased vasopressor requirements, and purulent endotracheal secretions. Blood and sputum cultures grow Klebsiella pneumoniae. Initial antimicrobial susceptibility testing reveals resistance to all tested penicillins, cephalosporins, and carbapenems. The patient is treated empirically with ceftazidime-avibactam based on local antibiogram data. However, 72 hours later, he remains febrile and hemodynamically unstable. Repeat susceptibility testing confirms that the isolate is resistant to ceftazidime-avibactam. Further specialized susceptibility testing reveals the isolate is susceptible to the combination of aztreonam and avibactam, as well as to cefiderocol. Which of the following best describes the underlying molecular mechanism responsible for this organism's specific resistance profile?

A 34-year-old man comes to the emergency department due to a 3-day history of high fever, severe sore throat, and easy bruising. Four weeks ago, he was diagnosed with severe ileocolonic Crohn disease and was started on a tapering dose of oral prednisone and azathioprine. His temperature is 39.2°C (102.6°F), blood pressure is 105/65 mm Hg, and pulse is 115/min. Physical examination shows pale conjunctivae, pharyngeal erythema with exudates, and scattered petechiae over the lower extremities.

Laboratory studies show:
Leukocyte count: 1,100/mm³
Absolute neutrophil count: 200/mm³
Hemoglobin: 8.2 g/dL
Platelet count: 35,000/mm³

The patient's condition is most likely due to an underlying genetic defect in which of the following molecular processes?

Match each clinical scenario describing a pharmacokinetic drug interaction to the primary underlying molecular mechanism responsible for the altered drug levels.

An infection control team is investigating a cluster of severe pseudomembranous colitis cases at a long-term care facility. Several residents developed profound, foul-smelling diarrhea, fever, and leukocytosis (with white blood cell counts exceeding $25,000/\text{mm}^3$) after receiving broad-spectrum antibiotics for various indications. Stool assays confirm the presence of a spore-forming, anaerobic, Gram-positive bacillus. The pathogen's major cytotoxin (Toxin B) causes massive disruption of the intestinal epithelial cytoskeleton through a highly specific intracellular cascade. Following the initial binding of this cytotoxin to host cell surface receptors (such as Frizzled-1 or CSPG4), arrange the subsequent pathophysiological events in the correct chronological sequence leading to cytoskeletal collapse.

A 34-year-old man with severe opioid use disorder presents to an outpatient addiction clinic requesting medication-assisted treatment. He reports that his last intravenous heroin use was approximately 2 hours ago. On examination, he appears comfortable with a heart rate of 78/min, blood pressure of 118/76 mm Hg, and respiratory rate of 14/min. Pupils are 3 mm bilaterally. The physician administers a standard induction dose of sublingual buprenorphine. Thirty minutes later, the patient becomes profoundly agitated, diaphoretic, and develops severe abdominal cramps, bone pain, and yawning. His heart rate increases to 112/min and his pupils dilate to 7 mm. Which of the following pharmacodynamic properties of the administered medication best explains this patient's acute physiological deterioration?

A 66-year-old man with metastatic non-small cell lung cancer is brought to the emergency department by his husband due to extreme lethargy, nausea, and intermittent confusion over the past four days. He has lost $4.5 \text{ kg}$ ($9.9 \text{ lbs}$) over the last month. His current oncologic regimen includes a monoclonal antibody targeting programmed cell death protein 1 (PD-1), which he has received every three weeks for the past four months. On presentation, his temperature is $37.1^\circ\text{C}$ ($98.8^\circ\text{F}$), blood pressure is $86/52 \text{ mmHg}$, and heart rate is $112\text{ /min}$. Physical examination reveals delayed capillary refill and generalized weakness.

Initial laboratory studies show:

Based on the patient's presentation and laboratory findings, which of the following best characterizes the fundamental immunopathologic event precipitating this patient's acute clinical deterioration?

Critically ill and medically complex patients frequently exhibit profound physiologic derangements that drastically alter drug disposition. For each patient scenario describing a specific clinical state and medication class, select the most accurate primary pharmacokinetic consequence and the corresponding required modification to therapy.

A 45-year-old man weighing $80 \text{ kg}$ is admitted to the intensive care unit with severe sepsis. He requires immediate intravenous administration of an antibiotic. The target peak plasma concentration ($C_p$) for this drug is $12 \text{ mg/L}$. Pharmacokinetic data indicates that the volume of distribution ($V_d$) for this antibiotic is $0.5 \text{ L/kg}$. What is the appropriate intravenous loading dose (in mg) required to achieve the desired target plasma concentration for this patient?

Match the following commonly used antithrombotic and anticoagulant agents with their primary foundational mechanism of action in the coagulation and hemodynamic pathways.